115 related articles for article (PubMed ID: 32602214)
1. Clinical and anthropometric characteristics of non-obese non-alcoholic fatty liver disease subjects in Japan.
Shida T; Oshida N; Suzuki H; Okada K; Watahiki T; Oh S; Kim T; Isobe T; Okamoto Y; Ariizumi SI; Yamamoto M; Shoda J
Hepatol Res; 2020 Sep; 50(9):1032-1046. PubMed ID: 32602214
[TBL] [Abstract][Full Text] [Related]
2. Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease.
Shida T; Akiyama K; Oh S; Sawai A; Isobe T; Okamoto Y; Ishige K; Mizokami Y; Yamagata K; Onizawa K; Tanaka H; Iijima H; Shoda J
J Gastroenterol; 2018 Apr; 53(4):535-547. PubMed ID: 28791501
[TBL] [Abstract][Full Text] [Related]
3. Progressive reduction in skeletal muscle mass to visceral fat area ratio is associated with a worsening of the hepatic conditions of non-alcoholic fatty liver disease.
Shida T; Oshida N; Oh S; Okada K; Shoda J
Diabetes Metab Syndr Obes; 2019; 12():495-503. PubMed ID: 31114278
[No Abstract] [Full Text] [Related]
4. Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
Kwak JH; Jun DW; Lee SM; Cho YK; Lee KN; Lee HL; Lee OY; Choi HS; Yoon BC
Clin Nutr; 2018 Oct; 37(5):1550-1557. PubMed ID: 28918170
[TBL] [Abstract][Full Text] [Related]
5. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of non-alcoholic steatohepatitis among lean patients in Japan: Not uncommon and not always benign.
Tobari M; Hashimoto E; Taniai M; Ikarashi Y; Kodama K; Kogiso T; Tokushige K; Takayoshi N; Hashimoto N
J Gastroenterol Hepatol; 2019 Aug; 34(8):1404-1410. PubMed ID: 30590868
[TBL] [Abstract][Full Text] [Related]
7. The relationship between non-alcoholic fatty liver and skeletal muscle mass to visceral fat area ratio in women with type 2 diabetes.
Su X; Xu J; Zheng C
BMC Endocr Disord; 2019 Jul; 19(1):76. PubMed ID: 31315613
[TBL] [Abstract][Full Text] [Related]
8. Ultrasonographic and biochemical evaluation of visceral obesity in obese women with non-alcoholic fatty liver disease.
Fenkci S; Rota S; Sabir N; Akdag B
Eur J Med Res; 2007 Feb; 12(2):68-73. PubMed ID: 17369120
[TBL] [Abstract][Full Text] [Related]
9. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
[TBL] [Abstract][Full Text] [Related]
10. Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol.
Yasutake K; Nakamuta M; Shima Y; Ohyama A; Masuda K; Haruta N; Fujino T; Aoyagi Y; Fukuizumi K; Yoshimoto T; Takemoto R; Miyahara T; Harada N; Hayata F; Nakashima M; Enjoji M
Scand J Gastroenterol; 2009; 44(4):471-7. PubMed ID: 19058085
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution.
Alferink LJM; Trajanoska K; Erler NS; Schoufour JD; de Knegt RJ; Ikram MA; Janssen HLA; Franco OH; Metselaar HJ; Rivadeneira F; Darwish Murad S
J Bone Miner Res; 2019 Jul; 34(7):1254-1263. PubMed ID: 31074909
[TBL] [Abstract][Full Text] [Related]
12. Fat mass to fat-free mass ratio and the risk of non-alcoholic fatty liver disease and fibrosis in non-obese and obese individuals.
Dai H; Xiang J; Hou Y; Xuan L; Wang T; Li M; Zhao Z; Xu Y; Lu J; Chen Y; Wang W; Ning G; Bi Y; Xu M
Nutr Metab (Lond); 2021 Feb; 18(1):21. PubMed ID: 33608033
[TBL] [Abstract][Full Text] [Related]
13. Regional anthropometric measures associated with the severity of liver injury in patients with non-alcoholic fatty liver disease.
Subramanian V; Johnston RD; Kaye P; Aithal GP
Aliment Pharmacol Ther; 2013 Feb; 37(4):455-63. PubMed ID: 23293873
[TBL] [Abstract][Full Text] [Related]
14. Relative Skeletal Muscle Mass Is an Important Factor in Non-Alcoholic Fatty Liver Disease in Non-Obese Children and Adolescents.
Kwon Y; Jeong SJ
J Clin Med; 2020 Oct; 9(10):. PubMed ID: 33086717
[TBL] [Abstract][Full Text] [Related]
15. Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008-2011).
Lee YH; Jung KS; Kim SU; Yoon HJ; Yun YJ; Lee BW; Kang ES; Han KH; Lee HC; Cha BS
J Hepatol; 2015 Aug; 63(2):486-93. PubMed ID: 25772036
[TBL] [Abstract][Full Text] [Related]
16. Low 25-hydroxyvitamin D level is associated with insulin sensitivity in obese adolescents with non-alcoholic fatty liver disease.
Pirgon O; Cekmez F; Bilgin H; Eren E; Dundar B
Obes Res Clin Pract; 2013; 7(4):e275-83. PubMed ID: 24306155
[TBL] [Abstract][Full Text] [Related]
17. Association of nonalcoholic fatty liver disease with cardiovascular risk factors in obese adolescents: the role of interdisciplinary therapy.
Sanches PL; de Piano A; Campos RM; Carnier J; de Mello MT; Elias N; Fonseca FA; Masquio DC; da Silva PL; Corgosinho FC; Tock L; Oyama LM; Tufik S; Dâmaso AR
J Clin Lipidol; 2014; 8(3):265-72. PubMed ID: 24793347
[TBL] [Abstract][Full Text] [Related]
18. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
[TBL] [Abstract][Full Text] [Related]
19. Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial.
Friedrich D; Marschall HU; Lammert F
BMC Gastroenterol; 2018 Jun; 18(1):76. PubMed ID: 29866129
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and metabolic abnormality of patients with non-alcoholic fatty liver disease: Either non-obese or obese Chinese population.
Lee SW; Lee TY; Yang SS; Tung CF; Yeh HZ; Chang CS
Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):45-48. PubMed ID: 29428103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
